DNA Script

DNA Script

A graduate of the Ecole des Mines de Paris (Civil Engineer 2007, Corps des Mines 2010), Sylvain began his career at the State Equity Agency before co-founding DNA Script in 2014.

Sylvain is the winner of the MIT Technology Review's Innovator of the Year Under 35 Award.

Born and (university) educated in South Africa, raised in Namibia and with work experience as a postdoc in the USA and afterwards as a Senior Scientist at Roche Sequencing Solutions (Cape Town), Wesley joined DNA Script (Paris) as a Senior Research Scientist during October 2019. Much of his previous scientific career was focused on utilizing experimental evolution to understand biological processes. Now, as a member of the enzyme engineering team at DNA Script, Wesley is harnessing the power of directed evolution to help engineer the proteins used in the DNA printing technology of DNA Script. In his free time, Wesley loves to travel adventurously, especially by bicycle. After his tenure in the USA, he travelled on his bicycle from Nairobi, Kenya, down to Cape Town, South Africa, a distance of nearly 9,000 km. During these travels, he also visited several African research institutions and, from his tent in the African bush, wrote blogs about science in Africa and the fight against the evolution of antibiotic resistance.

Once his doctorate in biochemistry was completed, Jérôme spent a few years at the Pasteur Institute to deepen his knowledge by studying DNA polymerases. Since the spring of 2018, he has been in charge of the enzyme production team, in charge of producing and purifying the different enzymes developed by DNA Script. Jérôme always sees the glass completely full and tends to make his good mood contagious. A great lover of board games, he also loves all kinds of gadgets and technological novelties. #gadgetophile #technophile.

After obtaining her Master's degree in Molecular and Cellular Biology, she worked for 4 years as a design engineer in a CNRS research team to study epigenetics. After an experience in the public sector, she wanted to join the world of biotech and decided to join a start-up company. She joined DNA Script in September 2019, as an engineer on the synthesis platform to participate in the development of this new DNA printer. In particular, she is setting up the reagent stability studies and the validation of all the elements necessary for DNA synthesis. A little bit of everything, when she is not doing new experiments in the laboratory, she experiments with new recipes in cooking, cosmetics or new sewing projects.

Faten has a doctorate in enzymatic engineering from INSA Toulouse. Before joining DNA Script in the summer of 2018, she worked for nearly three years on DNA polymerases and modified DNA in a research team in synthetic biology.

Faten is responsible for the characterisation of enzyme mutants generated by the enzyme engineering team. This involves validating their performance for use in the proprietary DNA synthesis process developed by DNA Script.

With his engineering degree in hand, Christophe started his career in the management of complex projects in Singapore and Egypt. He then joined the Pharmaceutical, Cosmetic and Veterinary Industry, which he has never left. From Engineering, HSE, Controlling, Investments, Supply Chain and General Management, on both sides of the Atlantic, Christophe has worked in almost every position...

At DNA Script there is (almost) everything to do: a challenge that Christophe could not miss under any circumstances! The opportunity to put his experience to good use in the service of a start-up in full development, where the industrialist is going to take an increasingly important place and create as many career opportunities. And outside of work, if you want to meet Christophe, it will be on the water... sometimes far from the coast... 

Henri is a graduate of the Ecole Polytechnique and the Ecole des Mines de Paris, specialising in biotechnology.

Henri joined DNA Script in 2017 upon completion of his studies. He is in charge of the design and manufacture of the DNA synthesis equipment used in the company's laboratories.

A pure product of organic chemistry, he has spent a large part of his career optimising chemical synthesis routes in the Paris region. He has worked for Sanofi and Servier as well as Descartes where he acquired a solid experience. He joined DNA SCRIPT 2 years ago in the modified nucleotides team in order to develop the technological possibilities of synthetic DNA creation. Crazy about badminton and football, he keeps smiling in all circumstances and transmits his joy of life on a daily basis!


DNA Script is a leading company in manufacturing de novo synthetic nucleic acids using enzymatic DNA synthesis (EDS) technology. The company aims at accelerating innovation in life science and technology through the decentralization of rapid, on demand and high-quality DNA synthesis. DNA Script's approach leverages nature's billions of years of evolution in synthesizing DNA to set a new standard for customizing nucleic acid synthesis thus accelerating discovery in genetics, genomics, and synthetic biology. Discovery disciplines with profound impacts upon humanity such as biopharma, translational genetics and even molecular information storage all start with synthetic DNA. The company has recently initiated the commercialization of its first EDS powered platform, the SYNTAX system.

To date, DNA Script has raised over $315M of financing, with leading investors such as Coatue Management, Fidelity Management and Research, Catalio Capital Management, Casdin Capital, LSP, Bpifrance Large Ventures, Danaher, Illumina Ventures, Agilent, Merck Ventures, Sofinnova Partners, Kurma Partners and Eurazeo.

DNA Script also partners on technology and product development with leading organizations such as DARPA, IARPA, Moderna Therapeutics, GE Research, Illumina, the Broad Institute, Harvard University, Institut Pasteur and the French Department of Defense.

DNA Script has its research and manufacturing facilities headquartered in Paris, France, and is in the process of expanding its commercial and development teams in South San Francisco.

What they are looking for

They’re above all science-driven thinkers, makers, dreamers and do-ers.

DNA Script is now moving to a new stage of development, i.e. commercialization. That’s why they are looking for new talents in different fields: R&D, manufacturing and supply chain, sales and marketing, industrial and IT engineering, quality, customer service, etc.

Are you passionate about life sciences, curious, motivated, proactive and you want to invest in a company with an innovative project? Do not hesitate to send them your application!

Good to know

Join DNA Script means :

  • 💗 Participate and bring to life a project that makes sense and will have a real impact on future generations
  • 🎓 Be part of a strong scientific and technical environment: a technology that pushes the limits of DNA synthesis and will power the bio-revolution of the 21st century. They already have several collaborations with MIT, Harvard, Moderna, GE Healthcare etc.
  • 💪 A scalable position: you will benefit from training, work on transversal projects, develop a new expertise, etc.
  • 🌍 Discover different cultures because at DNA Script we come from all over the world.
  • 🤗 Friday breakfast, afterworks and teambuildings frequently
  • 🏆 A management with values Excellence, transparency and kindness, where the well-being is not just a promess!

Embed this profile on your website